I, Avinash Clarke, as delegate of the Minister for Health and Ageing, make the following instrument.
Dated 23 October 2025
Avinash Clarke
Acting First Assistant Secretary
Medicines Regulation Division
Health Products Regulation Group
Department of Health, Disability and Ageing
1 Name
2 Commencement
3 Authority
4 Schedules
Schedule 1—Amendments
Therapeutic Goods (Serious Scarcity and Substitutable Medicine) (Labetalol) Instrument 2025
This instrument is the Therapeutic Goods (Serious Scarcity and Substitutable Medicine) (Labetalol) Amendment Instrument 2025.
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
Commencement information | ||
Column 1 | Column 2 | Column 3 |
Provisions | Commencement | Date/Details |
1. The whole of this instrument | 30 October 2025. | 30 October 2025 |
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
This instrument is made under section 30EK of the Therapeutic Goods Act 1989.
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
1 Section 7
Repeal the section, substitute:
7 Period instrument in force
This instrument remains in force until 31 December 2025.
2 Section 8
Repeal the section, substitute:
8 Repeals
Unless repealed earlier, this instrument is repealed at the start of 1 January 2026.